Tang F, Liang Y, Zhang L, Qiu L, Xu C
J Cardiothorac Surg. 2025; 20(1):24.
PMID: 39757175
PMC: 11702059.
DOI: 10.1186/s13019-024-03235-3.
Ghosh D, McDonald H, Dutta R, Krishnan K, Thilakan J, Paul M
Cells. 2024; 13(21.
PMID: 39513892
PMC: 11545304.
DOI: 10.3390/cells13211785.
Das S, Zea Rojas M, Tran E
Wiley Interdiscip Rev RNA. 2024; 15(4):e1864.
PMID: 39087253
PMC: 11626863.
DOI: 10.1002/wrna.1864.
Lin C, Lin K, Li P, Yuan H, Lin X, Dai Y
Sci Rep. 2024; 14(1):14460.
PMID: 38914679
PMC: 11196711.
DOI: 10.1038/s41598-024-65327-3.
Ye Y, Zhang Y, Luo Y, Xu A, Ji L
Am J Cancer Res. 2024; 14(2):655-678.
PMID: 38455404
PMC: 10915312.
Identification of prognosis-related lncRNAs and cell validation in lung squamous cell carcinoma based on TCGA data.
Cui Y, Wu Y, Zhang M, Zhu Y, Su X, Kong W
Front Oncol. 2023; 13:1240868.
PMID: 37965447
PMC: 10642190.
DOI: 10.3389/fonc.2023.1240868.
Immunogenic cell death-related long noncoding RNA influences immunotherapy against lung adenocarcinoma.
Sun D, Zhang C
Oncol Res. 2023; 31(5):753-767.
PMID: 37547766
PMC: 10398397.
DOI: 10.32604/or.2023.029287.
LncRNA FAM83A-AS1 promotes epithelial-mesenchymal transition of pancreatic cancer cells via Hippo pathway.
Wang H, Ding Y, Zhu Q, Yu Z, Wang Q, Gong A
Cell Cycle. 2023; 22(12):1514-1527.
PMID: 37245082
PMC: 10281461.
DOI: 10.1080/15384101.2023.2216507.
Regulation of early diagnosis and prognostic markers of lung adenocarcinoma in immunity and hypoxia.
Sun K, Zhang Z, Wang D, Huang Y, Zhang J, Lian C
Sci Rep. 2023; 13(1):6459.
PMID: 37081097
PMC: 10119119.
DOI: 10.1038/s41598-023-33404-8.
Significance of cuproptosis-related lncRNA signature in LUAD prognosis and immunotherapy: A machine learning approach.
Yang L, Cui Y, Liang L, Lin J
Thorac Cancer. 2023; 14(16):1451-1466.
PMID: 37076991
PMC: 10234775.
DOI: 10.1111/1759-7714.14888.
Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma.
Liu X, Fu M, Xia D, Ji Z, Hu N, Leng Z
J Oncol. 2022; 2022:8767333.
PMID: 36245969
PMC: 9556212.
DOI: 10.1155/2022/8767333.
Identifying General Tumor and Specific Lung Cancer Biomarkers by Transcriptomic Analysis.
Otalora-Otalora B, Osuna-Garzon D, Carvajal-Parra M, Canas A, Montecino M, Lopez-Kleine L
Biology (Basel). 2022; 11(7).
PMID: 36101460
PMC: 9313083.
DOI: 10.3390/biology11071082.
FAM83A antisense RNA 1 () silencing impairs cell proliferation and induces autophagy via MET-AMPKɑ signaling in lung adenocarcinoma.
Zhao H, Wang Y, Wu X, Zeng X, Lin B, Hu S
Bioengineered. 2022; 13(5):13312-13327.
PMID: 35635086
PMC: 9275865.
DOI: 10.1080/21655979.2022.2081457.
Identification of Fatty Acid Metabolism-Related lncRNAs as Biomarkers for Clinical Prognosis and Immunotherapy Response in Patients With Lung Adenocarcinoma.
Wang H, Cui J, Yu J, Huang J, Li M
Front Genet. 2022; 13:855940.
PMID: 35464865
PMC: 9023759.
DOI: 10.3389/fgene.2022.855940.
Identification and Validation of 7-lncRNA Signature of Epigenetic Disorders by Comprehensive Epigenetic Analysis.
Cao P, Li F, Xiao Y, Hu S, Kong K, Han P
Dis Markers. 2022; 2022:5118444.
PMID: 35237359
PMC: 8885251.
DOI: 10.1155/2022/5118444.
A two-phase comprehensive NSCLC prognostic study identifies lncRNAs with significant main effect and interaction.
Zhu J, Guan J, Ji X, Song Y, Xu X, Wang Q
Mol Genet Genomics. 2022; 297(2):591-600.
PMID: 35218396
PMC: 8960609.
DOI: 10.1007/s00438-022-01869-3.
Evaluation of the Prognostic Value of Long Noncoding RNAs in Lung Squamous Cell Carcinoma.
Zhang X, Su Y, Fu X, Xiao J, Qin G, Yu M
J Oncol. 2022; 2022:9273628.
PMID: 35069738
PMC: 8776467.
DOI: 10.1155/2022/9273628.
LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
Chen Z, Hu Z, Sui Q, Huang Y, Zhao M, Li M
Int J Biol Sci. 2022; 18(2):522-535.
PMID: 35002507
PMC: 8741836.
DOI: 10.7150/ijbs.67556.
Identification of a prognostic ferroptosis-related lncRNA signature in the tumor microenvironment of lung adenocarcinoma.
Guo Y, Qu Z, Li D, Bai F, Xing J, Ding Q
Cell Death Discov. 2021; 7(1):190.
PMID: 34312372
PMC: 8313561.
DOI: 10.1038/s41420-021-00576-z.
Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma.
Geng W, Lv Z, Fan J, Xu J, Mao K, Yin Z
Front Cell Dev Biol. 2021; 9:657667.
PMID: 33855028
PMC: 8039462.
DOI: 10.3389/fcell.2021.657667.